Anti-Kickback Statute

Gilead Sciences, Inc (NASDAQ: GILD) has agreed to pay $97 million to settle allegations that it illegally paid for Medicare co-pays for its own pulmonary arterial hypertension drug Letairis through a charitable entity. What Happened: The Foster City, California-based drugmaker allegedly used...